- Analytics
- News and Tools
- Market News
- Two doses of Pfizer vaccine give 70% protection against Omicron hospitalisation – Reuters
Two doses of Pfizer vaccine give 70% protection against Omicron hospitalisation – Reuters
According to a study released by South Africa's largest private health insurance administrator, Discovery Health, two doses of Pfizer-BioNTech vaccine give 70% protection against Omicron hospitalisation, as reported by Reuters.
Additional takeaways
"Two doses of Pfizer-BioNTech vaccine give 33% protection against infection during current wave."
"Study suggests risk of reinfection during current wave significantly higher than during previous waves."
"Study finds risk of hospitalisation among adults diagnosed with COVID-19 is 29% lower compared to infection in South Africa's first wave, adjusting for vaccination status."
"Study finds children have 20% higher risk of hospital admission with complications relative to the first wave, despite the very low absolute incidence."
"Analysis includes more than 211,000 positive COVID-19 test results, roughly 78,000 of which were attributed to Omicron, over Nov. 15-Dec. 7."
Market reaction
This headline doesn't seem to be having a significant impact on market sentiment. As of writing, the S&P Futures were flat on the day.
© 2000-2024. All rights reserved.
This site is managed by Teletrade D.J. LLC 2351 LLC 2022 (Euro House, Richmond Hill Road, Kingstown, VC0100, St. Vincent and the Grenadines).
The information on this website is for informational purposes only and does not constitute any investment advice.
The company does not serve or provide services to customers who are residents of the US, Canada, Iran, The Democratic People's Republic of Korea, Yemen and FATF blacklisted countries.
Making transactions on financial markets with marginal financial instruments opens up wide possibilities and allows investors who are willing to take risks to earn high profits, carrying a potentially high risk of losses at the same time. Therefore you should responsibly approach the issue of choosing the appropriate investment strategy, taking the available resources into account, before starting trading.
Use of the information: full or partial use of materials from this website must always be referenced to TeleTrade as the source of information. Use of the materials on the Internet must be accompanied by a hyperlink to teletrade.org. Automatic import of materials and information from this website is prohibited.
Please contact our PR department if you have any questions or need assistance at pr@teletrade.global.
Bank transfers
